Clinical Trial Update: Registry on WATCHMAN Outcomes in Real-Life Utilization

View source ↗

Summary

A completed registry study evaluating WATCHMAN device outcomes in real-life use for patients with atrial fibrillation at risk of thrombus formation and stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke
• Thromboembolism

Drugs mentioned

• Watchman

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke | Status: COMPLETED | Results posted: 2019-05-07